propranolol hydrochloride 160 mg capsule: modified release
Cardinol LA 160 mg capsule: sustained release, 30 capsules, blister pack
Cardinol LA 160 mg capsule: sustained release, 100 capsules, bottle
Sub $18.17 per 100
propranolol hydrochloride 1 mg/mL injection, ampoule
propranolol hydrochloride 1 mg/mL injection, vial
Dociton 1 mg/mL injection: solution, ampoule, 10 x 1 mL ampoules
S29
Inderal 1 mg/mL injection: solution, 10 x 1 mL ampoules
S29
Propranolol Hydrochloride (APP) 1 mg/mL injection: solution, 10 x 1 mL vials
S29
propranolol hydrochloride 20 mg/5 mL oral liquid
Propranolol Hydrochloride (West-Ward) 20 mg/5 mL oral liquid: solution, 500 mL, bottle
S29
Roxane-Propranolol 20 mg/5 mL oral liquid: solution, 500 mL, bottle
SA
S29
propranolol hydrochloride 10 mg tablet
propranolol hydrochloride 40 mg tablet
propranolol hydrochloride 160 mg tablet
Cardinol 10 mg tablet: film-coated, 100 tablets, bottle [Obsolete]
S29
Cardinol 160 mg tablet: film-coated, 50 tablets, bottle [Obsolete]
S29
Cardinol 160 mg tablet: film-coated, 250 tablets, bottle [Obsolete]
S29
Cardinol 40 mg tablet: film-coated, 100 tablets, bottle [Obsolete]
S29
Apo-Propranolol (Section 29) 10 mg tablet: uncoated, 100 tablets, bottle
S29
Apo-Propranolol 10 mg tablet: uncoated, 100 tablets, bottle
Apo-Propranolol 10 mg tablet: uncoated, 500 tablets, bottle [Obsolete]
S29
Apo-Propranolol (Section 29) 40 mg tablet: uncoated, 100 tablets, bottle
S29
Apo-Propranolol 40 mg tablet: uncoated, 100 tablets, bottle
Apo-Propranolol 40 mg tablet: uncoated, 500 tablets, bottle [Obsolete]
S29
Drofate 10 mg tablet: uncoated, 90 tablets, bottle
Drofate 10 mg tablet: uncoated, 100 tablets, bottle
Sub $7.04 per 100
Drofate 40 mg tablet: uncoated, 100 tablets, bottle
Ipca-Propranolol 10 mg tablet: uncoated, 100 tablets, bottle
Ipca-Propranolol 40 mg tablet: uncoated, 100 tablets, bottle
Sub $8.75 per 100
*Section 29 Medicines
This medicine has not been approved for use in New Zealand and as such may only be supplied under Section 29.
Further information is available from:
http://www.medsafe.govt.nz/regulatory/unapproved.asp
This medicine has been listed in the NZULM because it has been supplied to a
medical practitioner for the treatment of a named patient under their care in New Zealand.
An NZULM listing is in no way indicative of medicines availability, nor does it constitute an advertisement.
Content Status
At present, almost all regularly prescribed medicines are available in the NZULM.
OTC, un-subsidised, Section 29, and discontinued medicines are continuously being added.
Generic
Brand
Fully subsidised